Avril 2005

The life sciences industries are strategic sectors undergoing significant change. To better understand the issues facing the industries and their implications, Deloitte, in collaboration with the Economist Intelligence Unit (EIU), has recently completed a white paper on the future of the life sciences industries.

The white paper, entitled "The Future of the life sciences industries", was based upon an online survey completed by 206 senior industry executives from around the world, in-depth interviews with life sciences executives, and an executive forum that brought leaders together to discuss the survey and interview results. The white paper includes research and observations on the strategic priorities over the next 10 years, where the main challenges lie and how executives intend to seize opportunities. It lays out the challenges facing the pharmaceuticals sector and presents the possibilities of the growing biotech sector. Main points of the white paper include:

• Impeding industry consolidation and convergence
• Divergence of pharma and biotech futures
• Expansion of Asian life sciences markets
• Growing importance and difficulties with innovation
• Decline in industry reputation and its effects
• Globalization

Anglais uniquement